Suscribirse

Sleep apneas treatment during cardiac rehabilitation can improve heart failure prognosis? SATELIT-HF - 21/12/15

Doi : 10.1016/j.rmr.2015.10.032 
M.C. Iliou 1, , S. Corone 2, B. Gellen 3, T. Denolle 4, F. Roche 5, A. Bellemain-Apaix 6, M. Bigot 7, M. Lopes 8, S. Durand 9, C. Darné 10
1 AP–HP, Issy-Les-Moulineaux, France 
2 CH Bligny, Briis S Forges, France 
3 AP–HP, Créteil, France 
4 Hôpital A.- Gardiner, Dinard, France 
5 Hôpital Nord Saint-Étienne, Saint-Priest, France 
6 Clinique La Maison du Mineur, Vence, France 
7 Clinique Cardiocean, Puilboreau, France 
8 Clinique de La Mitterie, Lhomme, France 
9 Clinique de Chatillon, Chatillon, France 
10 CH Bligny, Briis S Forges, France 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Resumen

Introduction

Sleep-disordered breathing (SDB) is commonly in chronic heart failure (CHF) patients. Exercise training (ET) improves exercise tolerance and reduces cardiac decompensations in CHF population. Otherwise, ventilation therapy (VT) improves prognosis and exercise capacity in CHF patients with SDB. However, the effect of the combination therapy: ET and VT is still unexplored. The aim of our study is to evaluate the effects on hemodynamic status (cardiac decompensations) of ET and VT in stable CHF patients referred to cardiac rehabilitation (CR).

Methods

We included 118 stable CHF patients with an apnea-hypopnea index (AHI)>15/h diagnosed by polygraphy. They were randomized into exercise training (ET group n=58) or combined exercise and ventilation (ET+VT group n=60). The follow up period was the 8 weeks during which 20 exercise training sessions were scheduled. Severe episodes of cardiac decompensations were recorded.

Results

The mean age was 62.6±10.3 years, 89% were males, 50% NYHA class II and 50% in class III, mean LVEF was 30%. 40% and 60% of patients had respectively obstructive and central and/or mixed apneas, with a mean AHI 34.4±14.3/h. Patients of ET+VT group had significantly fewer acute cardiovascular events than those of ET group (2/60 vs. 9/58; 3.3% vs. 15.5%, P<0.05) and fewer cardiac decompensations (2/60 vs. 7/58; 3.3 vs 12%, P<0.05). This difference is particularly significant in obstructive sleep apneas patients.

Conclusion

Ventilation therapy combined with ET in severe CHF patients seems to reinforce benefits of ET alone. Screening of SDB in CR could be proposed in order to optimize the global management of the heart disease.

El texto completo de este artículo está disponible en PDF.

Esquema


© 2015  Publicado por Elsevier Masson SAS.
Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 33 - N° S

P. A14 - janvier 2016 Regresar al número
Artículo precedente Artículo precedente
  • Association entre la sévérité du syndrome d’apnée du sommeil et le contrôle glycémique chez les patients diabétiques traités et non traités
  • P. Priou, M. Le Vaillant, N. Meslier, S. Chollet, T. Pigeanne, P. Masson, A. Bizieux-Thaminy, M. Humeau, F. Goupil, P. Ducluzeau, F. Gagnadoux
| Artículo siguiente Artículo siguiente
  • Bénéfice cardio-métabolique du réentraînement à l’effort chez des patients obèses apnéiques traités par PPC : impact respectif du support ventilatoire à l’effort et de l’entraînement des muscles respiratoires
  • I. Vivodtzev, R. Tamisier, M. Croteau, A. Grangier, J. Borel, A. Borel, B. Wuyam, P. Lévy, C. Minville, F. Sériès, F. Maltais, J. Pépin